首页> 外国专利> procedure to increase the analgesic effect and reduce the adverse effects of exitatorischen bimodalisch effective opioidagonisten by inhibition of gm1 - gangliosid

procedure to increase the analgesic effect and reduce the adverse effects of exitatorischen bimodalisch effective opioidagonisten by inhibition of gm1 - gangliosid

机译:抑制gm1-神经节苷脂以提高镇痛作用并减少阿米沙星有效阿片样激动剂的副作用

摘要

The present invention provides a method for increasing analgesic potency of a bimodally-acting opioid agonist in a subject, by inhibiting GM1-ganglioside in nociceptive neurons. The present invention further provides a method for treating pain in a subject in need of treatment thereof. Also provided in the present invention is a method for treating chronic pain in a subject in need of treatment thereof. Additionally, the present invention provides a method for treating tolerance to or an addiction to a bimodally-acting opioid agonist in a subject in need of treatment thereof. Finally, the present invention provides a pharmaceutical composition of analgesic agents and a pharmaceutically-acceptable carrier.
机译:本发明提供了一种通过抑制伤害性神经元中的GM1-神经节苷脂来增加受试者中的双峰作用阿片样激动剂的止痛效力的方法。本发明进一步提供了一种在需要治疗的受试者中治疗疼痛的方法。本发明还提供了一种在需要治疗的受试者中治疗慢性疼痛的方法。另外,本发明提供了一种在需要治疗的受试者中治疗对双峰作用阿片激动剂的耐受性或成瘾性的方法。最后,本发明提供了止痛药和药学上可接受的载体的药物组合物。

著录项

  • 公开/公告号DE60236496D1

    专利类型

  • 公开/公告日2010-07-08

    原文格式PDF

  • 申请/专利号DE20026036496T

  • 发明设计人 CRAIN STANLEY M.;SHEN KE-FEI;

    申请日2002-03-19

  • 分类号A61K38;A61K45/06;A61K31;A61K31/135;A61K31/137;A61K31/215;A61K31/4465;A61K31/451;A61K31/4748;A61K31/485;A61K33;A61K33/04;A61K38/22;A61K38/33;A61K39/395;A61P25/04;A61P25/20;A61P43;

  • 国家 DE

  • 入库时间 2022-08-21 18:27:06

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号